Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
30 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
131.9 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
14
14 articles ont été cités au moins 14fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
950
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
68
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
17
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université de Tours · Centre Hospitalier Universitaire de Tours · Hôpital Bretonneau
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Meningeal Embolization for Preventing Chronic Subdural Hematoma Recurrence After Surgery
2025ArticleJAMA Cardiology
Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial
2025ArticleJournal of Neurosurgery
Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study
2023ArticleInterventional Neuroradiology
Patient Selection in a Pragmatic Study on the Management of Patients with Brain Arteriovenous Malformations
2023ArticleWorld Neurosurgery
Endovascular treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
2022ArticleJournal of Neurosurgery
Surgical treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
2022ArticleJournal of Neurosurgery
Impact of COVID‐19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID‐19 patients with acute ischemic stroke
2022ArticleJournal of Thrombosis and Haemostasis
Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak
2020ArticleStroke
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET PRIVE DU DR RICHARD BIBI
C.H.R.U. BRETONNEAU - TOURS 2 BD TONNELLE, 37044 TOURS CEDEX 9
CHRU BRETONNEAU - TOURS
2 BD TONNELLE, 37044 TOURS CEDEX 9
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of neurointerventional surgery · 2022
BackgroundThe primary goal of the CLARYS study is to assess the protection against rebleeding when treating ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) device.MethodsThe CLARYS study is a prospective, multicenter study conducted in 13 European centers. Patients with ruptured bifurcation aneurysms were consecutively included between February 2016 and September 2017. The primary endpoint was defined as the rebleeding rate of the target aneurysm treated with the WEB within 30 days postprocedure. Secondary endpoints included periprocedural and postprocedural adverse events, total procedure and fluoroscopy times, and modified Rankin Scale score at 1 month and 1 year.ResultsSixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. A WEB device was successfully implanted in 93.3%. The rebleeding rate at 1 month and 1 year was 0%. The mean fluoroscopy time was 27.0 min. Twenty-three periprocedural complications were observed in 18 patients and resolved without sequelae in 16 patients. Two of these complications were attributed to the procedure and/or the use of the WEB, leading to a procedure/device-related intraoperative complication rate of 3.3%. Overall mortality at 1 month and 1 year was 1.7% and 3.8%, respectively and overall morbidity at 1 month and 1 year was 15% and 9.6%, respectively. WEB-related 1-month and 1-year morbidity and mortality was 0%.ConclusionsThe interim results of CLARYS show that the endovascular treatment of ruptured bifurcation aneurysms with the WEB is safe and effective and, in particular, provides effective protection against rebleeding. It may induce profound change in the endovascular management of ruptured bifurcation aneurysms.
Neurosurgery · 2019
Abstract BACKGROUND Dual antiplatelet therapy (DAPT) associating aspirin + clopidogrel is commonly utilized in neurovascular interventions despite unpredictable clopidogrel efficacy with 4% to 50% of patients considered nonresponders. Ticagrelor is an antiplatelet agent with low resistance rates but unknown efficacy and safety in neurovascular patients. OBJECTIVE To evaluate frequency of ischemic and hemorrhagic events in patients treated with aspirin and ticagrelor when associated with perioperative heparin bolus for unruptured aneurysms treated with intracranial stents. METHODS One hundred fifty-four consecutive patients with unruptured intracranial aneurysms treated by stent procedures (113 = flow diverter stent [FDS], 41 = stent-assisted coiling) were retrospectively analyzed. All patients received aspirin and ticagrelor without platelet function testing. Patients were separated in 2 groups following perioperative heparin dose: group I = 70 U/kg; group II = 50 U/kg. FDS versus stent-assisted coiling procedures were also separately analyzed. RESULTS Nine patients (5.8%) presented symptomatic neurological complications poststenting (3 ischemic, 6 hemorrhagic): 8 patients received 70 U/kg of heparin (11.1%) and 1 patient received 50 U/kg (1.2%; P < .009). Four patients died (2.6%) during the 3-mo follow-up period—all deaths were correlated to intracranial hemorrhage: 3 at group I and 1 at group II (P < .251). No difference in complications or death was observed considering separately FDS and stent-assisted coiling procedures. CONCLUSION This study did not find more neurological complications than in previous neurointerventional reports using DAPT with aspirin + ticagrelor or aspirin + clopidogrel. Overall number of neurological complications was lower when a lower dose of heparin was administered. Neurovascular studies comparing clopidogrel to ticagrelor and different doses of heparin are necessary to demonstrate which association is more efficient with lower complication rates.
Journal of neurointerventional surgery · 2023
BackgroundThe CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS) study has shown that the endovascular treatment of ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) is safe and effective and provides protection against rebleeding at 1 month and 1 year. The 12-month angiographic follow-up is an important endpoint of the study.MethodsThe CLARYS study is a prospective multicenter study conducted in 13 European centers. The study enrolled 60 patients with 60 ruptured aneurysms of the anterior and posterior circulation. The study was conducted with an independent assessment of safety outcomes and imaging.ResultsSixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. Fifty-three aneurysms (88.3%) had a broad base with a dome to neck ratio <2 (mean 1.6). Of these, 46 patients were evaluated by an independent core laboratory with follow-up imaging performed at 12 months or before eventual retreatment. At 1 year, 19/46 aneurysms (41.3%) were completely occluded (Raymond–Roy grade I), 21/46 (45.7%) had a residual neck and 6/46 (13.0%) had residual aneurysm filling. Adequate occlusion was reported in 40/46 (87%) aneurysms. Six patients underwent target aneurysm retreatment.ConclusionsThe CLARYS study has previously shown that the use of the WEB in the endovascular treatment of ruptured bifurcation aneurysms provides effective protection against rebleeding with a good safety profile. The angiographic occlusion rates at 1 year reported here are comparable to those already seen in previous multicenter studies which primarily included unruptured aneurysms.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of neurointerventional surgery · 2026 · Journal Article
Barrot V, Simon C, Donnard B, Catanese S, et al.
Clinical neuroradiology · 2026 · Letter
Donnard B, Bibi R, Kaesmacher J, Janot K
Cardiovascular and interventional radiology · 2026 · Letter
Ifergan H, Pilloy J, Barrot V, Janot K, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025 · Journal Article
Janot K, Charbonnier G, Marnat G, Sporns P, et al.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2025 · Journal Article
Simon C, Barrot V, Mortemousque G, Catanese S, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025 · Journal Article
Donnard B, Boulouis G, Kuntz C, Bala F, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Donnard B, Janot K, Ifergan H, Barrot V, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Mouyal SJ, Granger B, Janot K, Ifergan H, et al.
American journal of translational research · 2025 · Journal Article
Saleem SS, Bibi R, Gillani SMUM, Alqahtani N, et al.
Cureus · 2024 · Journal Article
Iqbal S, Khan IA, Khan MK, Ain QU, et al.
Journal of neurointerventional surgery · 2023 · Multicenter Study
Spelle L, Herbreteau D, Caroff J, Barreau X, et al.
Journal of neuroradiology = Journal de neuroradiologie · 2023 · Journal Article
Bankole NDA, Janot K, Kamounye US, Barrot V, et al.
Acta neurochirurgica · 2022 · Journal Article
Masson A, Boulouis G, Janot K, Herbreteau D, et al.
Journal of neuroradiology = Journal de neuroradiologie · 2022 · Journal Article
Cohen C, Gaillot K, Ifergan H, Dejobert M, et al.
Journal of thrombosis and haemostasis : JTH · 2022 · Journal Article
Desilles JP, Solo Nomenjanahary M, Consoli A, Ollivier V, et al.
Abdominal radiology (New York) · 2021 · Journal Article
Ifergan H, Perus T, Janot K, Kerleroux B, et al.
Clinical neurology and neurosurgery · 2021 · Journal Article
Kerleroux B, Tomasino C, Soriano D, Rodrigues PG, et al.
Journal of neuroradiology = Journal de neuroradiologie · 2020 · Journal Article
Janot K, Herbreteau D, Amelot A, Charbonnier G, et al.
Presse medicale (Paris, France : 1983) · 2019 · Journal Article
Janot K, Charbonnier G, Boustia F, Lima Maldonado I, et al.
World neurosurgery · 2019 · Journal Article
Narata AP, Janot K, Bibi R, Herbreteau D, et al.
Neurosurgery · 2019 · Journal Article
Narata AP, Amelot A, Bibi R, Herbreteau D, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026 · Journal Article
Salim HA, Scarcia L, Clarençon F, Hajjeh O, et al.
Neurosurgery · 2025 · Journal Article
Donnard B, Bala F, Boulouis G, Herbreteau D, et al.
The neuroradiology journal · 2024 · Journal Article
Bibi R, Bankole NDA, Donnard B, Giubbolini F, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Scarcia L, Clarençon F, Dmytriw AA, Shotar E, et al.
The neuroradiology journal · 2025 · Journal Article
Bankole NDA, Donnard B, Boulouis G, Nalbach Y, et al.
Healthcare (Basel, Switzerland) · 2024 · Journal Article
Ratti M, Ceriotti D, Rescinito R, Bibi R, et al.
Cureus · 2023 · Case Reports
Shafique Ur Rehman M, Subhan M, Gulraiz S, Bibi R, et al.
Cureus · 2024 · Journal Article
Tariq F, Ahmad M, Subhan M, Zaid Alvi SM, et al.
Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study
BackgroundThe occurrence of persistent intra-device filling (BOSS 1, using the Bicêtre Occlusion Scale Score (BOSS)) in aneurysms treated with a Woven Endobridge (WEB) device is infrequent based on angiographic follow-up
Persistent flow inside the Woven EndoBridge at angiographic follow-up: A multicenter study
BackgroundThe occurrence of persistent intra-device filling (BOSS 1, using the Bicêtre Occlusion Scale Score (BOSS)) in aneurysms treated with a Woven Endobridge (WEB) device is infrequent based on angiographic follow-up
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Journal of neurointerventional surgery · 2022 · Journal Article
Spelle L, Herbreteau D, Caroff J, Barreau X, et al.